EPISODE · Jul 9, 2026 · 4 MIN
Brazil ANVISA Regulatory Reliance: IN 290/2024 Changes for Class III & IV Devices
from Medical Device Global Market Access
Brazil's ANVISA has implemented a more flexible amendment process for its regulatory reliance pathway for high-risk medical devices under Normative Instruction 290/2024. Effective June 2026, this change allows ANVISA to issue questions and request revisions for Class III and IV device submissions based on approvals from Comparable Foreign Regulatory Authorities (AREEs), rather than issuing an outright rejection for minor issues. This episode details the new interactive process, who is affected, and the practical steps manufacturers should take to leverage this more efficient pathway to the Brazilian market. Key Questions: - What is Brazil's new regulatory reliance process under IN 290/2024? - How does this change affect Class III and IV medical device manufacturers? - Which foreign regulatory approvals are recognized by ANVISA for this pathway? - What was the old submission process, and why is the new one more efficient? - How can manufacturers avoid outright rejection of their reliance submissions? - What practical steps should regulatory teams take to adapt to this change? - When did this new, more flexible process become effective? - Does this change reduce the documentation requirements for ANVISA submissions? Sources: - https://www.emergobyul.com/news/regulatory-reliance-authorizations-brazils-revised-anvisa-process-june-2026 How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with a combination of local expertise and advanced AI. Our team helps you navigate complex landscapes like Brazil's ANVISA requirements, from initial regulatory strategy and technical dossier preparation to post-market surveillance. We act as your local representative in over 30 markets, using a single, efficient process to unlock multiple regions. Leverage our free AI tools and extensive device database at https://pureglobal.ai to accelerate your research, or contact us at [email protected] and visit https://pureglobal.com to learn how we can get your product to market faster.
NOW PLAYING
Brazil ANVISA Regulatory Reliance: IN 290/2024 Changes for Class III & IV Devices
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.